| 1 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. 2012 · Nature | | 3,758 |
| 2 | The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. 1991 · Arthritis Rheum | | 1,922 |
| 3 | Crohn's disease. 2012 · Lancet | | 1,626 |
| 4 | TNF-mediated inflammatory disease. 2008 · J Pathol | | 1,528 |
| 5 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders Magro · 2017 · J Crohns Colitis | | 1,445 |
| 6 | Inflammatory bowel disease: clinical aspects and established and evolving therapies Baumgart · 2007 · Lancet | | 1,444 |
| 7 | Therapeutic roles of curcumin: lessons learned from clinical trials. 2013 · AAPS J | | 1,278 |
| 8 | The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. 2011 · Ann Rheum Dis | | 1,236 |
| 9 | Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. 2008 · Pharmacol Ther | | 1,230 |
| 10 | The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Greenstein · 1976 · Medicine (Baltimore) | | 1,063 |
| 11 | Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Itzkowitz SH · 2004 · Am J Physiol Gastrointest Liver Physiol | | 1,020 |
| 12 | Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. 2004 · Gastroenterology | | 975 |
| 13 | Development and validation of a pediatric Crohn's disease activity index. 1991 · J Pediatr Gastroenterol Nutr | | 964 |
| 14 | Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. 2010 · Nature | | 924 |
| 15 | Intestinal inflammation and cancer. Ullman TA · 2011 · Gastroenterology | | 915 |
| 16 | Diagnosis and management of primary sclerosing cholangitis. 2010 · Hepatology | | 875 |
| 17 | Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. 2009 · Altern Med Rev | | 836 |
| 18 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. 2015 · N Engl J Med | | 807 |
| 19 | European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. 2015 · J Eur Acad Dermatol Venereol | | 807 |
| 20 | CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. 2002 · Am J Hum Genet | | 795 |
| 21 | ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. 2023 · Ann Rheum Dis | | 786 |
| 22 | Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? 2021 · Nat Rev Immunol | | 756 |
| 23 | CARD15 mutations in Blau syndrome. 2001 · Nat Genet | | 748 |
| 24 | Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Chapman RW · 1980 · Gut | | 740 |
| 25 | Risk factors for cholangiocarcinoma. 2011 · Hepatology | | 715 |
| 26 | Primary sclerosing cholangitis - a comprehensive review. 2017 · J Hepatol | | 670 |
| 27 | Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. 2021 · Gastroenterology | | 659 |
| 28 | Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. 2003 · Rheumatol Int | | 639 |
| 29 | Spondyloarthritis. 2011 · Lancet | | 632 |
| 30 | Behçet's disease. Report of 41 cases and a review of the literature. 1975 · Medicine (Baltimore) | | 609 |
| 31 | Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. 2016 · Nat Genet | | 585 |
| 32 | Inflammatory Bowel Disease in Children and Adolescents. 2015 · JAMA Pediatr | | 581 |
| 33 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. Gionchetti P · 2017 · J Crohns Colitis | | 579 |
| 34 | The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. 2016 · J Crohns Colitis | | 570 |
| 35 | Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. 2007 · Medicine (Baltimore) | | 569 |
| 36 | The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. 2001 · Am J Gastroenterol | | 567 |
| 37 | Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. 2013 · Hepatology | | 560 |
| 38 | PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Loftus · 2005 · Gut | | 558 |
| 39 | Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. 2022 · Lancet | | 541 |
| 40 | Ulcerative Colitis in Adults: A Review. Gros · 2023 · JAMA | | 527 |
| 41 | Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. 2002 · J Hepatol | | 526 |
| 42 | Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. 1989 · Hepatology | | 506 |
| 43 | Extraintestinal Manifestations of Inflammatory Bowel Disease. 2015 · Inflamm Bowel Dis | | 501 |
| 44 | New IBD genetics: common pathways with other diseases. 2011 · Gut | | 497 |
| 45 | Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. 2022 · Nat Rev Rheumatol | | 477 |
| 46 | Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. 1974 · Medicine (Baltimore) | | 476 |
| 47 | Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. 1993 · Drugs | | 470 |
| 48 | Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. 1991 · Hum Pathol | | 466 |
| 49 | How to diagnose axial spondyloarthritis early. 2004 · Ann Rheum Dis | | 465 |
| 50 | THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. 1964 · Gut | | 464 |
| 51 | Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. 2006 · Gut | | 464 |
| 52 | Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. 2012 · J Hepatol | | 462 |
| 53 | Primary sclerosing cholangitis. 2013 · Lancet | | 454 |
| 54 | National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Rankin GB · 1979 · Gastroenterology | | 443 |
| 55 | Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. 2013 · Ann Rheum Dis | | 439 |
| 56 | Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. 2002 · Gastrointest Endosc | | 439 |
| 57 | Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. 2001 · Hepatology | | 439 |
| 58 | An update on the epidemiology of inflammatory bowel disease in Asia. 2008 · Am J Gastroenterol | | 437 |
| 59 | Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind · 2006 · Am J Gastroenterol | | 430 |
| 60 | Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Farmer RG · 1985 · Gastroenterology | | 428 |
| 61 | Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. 2013 · Nat Genet | | 428 |
| 62 | Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. 2011 · Am J Gastroenterol | | 423 |
| 63 | Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. 2012 · Gastroenterology | | 422 |
| 64 | European evidence based consensus on the diagnosis and management of Crohn's disease: current management. 2006 · Gut | | 421 |
| 65 | Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Weismüller · 2017 · Gastroenterology | | 412 |
| 66 | Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. 2003 · Gastroenterology | | 393 |
| 67 | Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition Turner · 2018 · J Pediatr Gastroenterol Nutr | | 387 |
| 68 | Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? 2004 · Gut | | 386 |
| 69 | A comprehensive review and update on Crohn's disease. Gajendran M · 2018 · Dis Mon | | 382 |
| 70 | Pyoderma gangrenosum: a review of 86 patients. 1985 · Q J Med | | 379 |
| 71 | Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. 2019 · J Am Acad Dermatol | | 376 |
| 72 | Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review. 2011 · Am J Gastroenterol | | 375 |
| 73 | Crohn Disease: Epidemiology, Diagnosis, and Management. Feuerstein JD · 2017 · Mayo Clin Proc | | 374 |
| 74 | Current concepts. Primary sclerosing cholangitis. 1984 · N Engl J Med | | 373 |
| 75 | Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis Penna · 1996 · Gut | | 371 |
| 76 | ACG Clinical Guideline: Primary Sclerosing Cholangitis. 2015 · Am J Gastroenterol | | 361 |
| 77 | Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. 2019 · Nat Microbiol | | 360 |
| 78 | Primary sclerosing cholangitis. 2018 · Lancet | | 356 |
| 79 | The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. 2017 · Gut | | 352 |
| 80 | Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. 2006 · Dan Med Bull | | 350 |
| 81 | Smoking habits and recurrence in Crohn's disease. 1994 · Gastroenterology | | 349 |
| 82 | Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans. 2020 · Cell | | 348 |
| 83 | Update on spondyloarthropathies. 2002 · Ann Intern Med | | 347 |
| 84 | Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Peyrin-Biroulet L · 2016 · Clin Gastroenterol Hepatol | | 346 |
| 85 | Clinical features and natural history of Crohn's disease. Mekhjian HS · 1979 · Gastroenterology | | 345 |
| 86 | Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. 2008 · World J Gastroenterol | | 344 |
| 87 | Pyoderma gangrenosum: an updated review. 2009 · J Eur Acad Dermatol Venereol | | 344 |
| 88 | Extraintestinal manifestations of inflammatory bowel disease. 2011 · Gastroenterol Hepatol (N Y) | | 340 |
| 89 | Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. 2001 · Ann Intern Med | | 337 |
| 90 | Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. 2016 · Gut | | 336 |
| 91 | Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. 1995 · Hepatology | | 336 |
| 92 | Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York. 2020 · N Engl J Med | | 335 |
| 93 | Ulcerative Colitis. 2019 · Mayo Clin Proc | | 327 |
| 94 | Optimizing anti-TNF treatment in inflammatory bowel disease. Rutgeerts P · 2004 · Gastroenterology | | 327 |
| 95 | American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. 2016 · Arthritis Rheumatol | | 323 |
| 96 | Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Itzkowitz Steven · 2004 · Gastroenterology | | 322 |
| 97 | Recent insights into the genetics of inflammatory bowel disease. Cho JH · 2011 · Gastroenterology | | 321 |
| 98 | Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. 2003 · Gastroenterology | | 320 |
| 99 | Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. 2015 · Ann Rheum Dis | | 319 |
| 100 | Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies Triantafillidis · 2009 · Anticancer Res | | 318 |